Albumin: don't confuse us with the facts

Publisher Website
Google Scholar
Abstract
References ↵ Schierhout G, Roberts I Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: a systematic review of randomised trials.BMJ1998; 316:961–964. ↵ Cochrane Injuries Group Albumin Reviewers Human albumin administration in crtically ill patients: systematic review of randomised controlled trials.BMJ1998; 317:235–240. ↵Human albumin administration in critically ill patients [letters]BMJ1998; 317:882–886. ↵Fluid resuscitation with colloid or crystalloid solutions [letters]BMJ1998; 317:277–279. ↵ Soni N Wonderful albumin.BMJ1995; 310:887. ↵ McClelland DBL In: McClelland DBL, ed. Handbook of transfusion medicine. 2nd ed. London: HMSO1996. ↵ Committee for Proprietary Medicinal Products Core summary of product characteristics for human albuminBrussels: Commission of the European Communities1992. ↵Giving albumin increases mortality in critically ill patients [This week in the BMJ]BMJ1998; 317 (7153). ↵ Chalmers I What is going on behind the scenes in the debate about albumin. http://www.bmj.com/cgi/eletters/317/7153/235#EL9. ↵ Fergal D Letter to doctorsWashington, DC: Food and Drug Administration, Center for Biologics Evaluation and Research1998 (http://www.fda.gov/medwatch/safety/1998/plasma.htm) ↵ Rawlins MD Human albumin therapy in critically ill patientsLondon: Committee on Safety of Medicine1998(CEM/CMO/98/11.) ↵ Sirchia G, Giovanetti AM, Baele PL, Carrington da Costa RB, Drouet N, ten Duis HJ, et al. Use of blood products for elective surgery in 43 European hospitals.Transfus Med1994; 4:251–268. ↵ Brennan TA, Leape LL, Laird NM, Hebert L, Logalio AR, Lawthers AG, et al. Incidence of adverse events and negligence in hospitalized patients.New Engl J Med1991; 324:370–376.